Resilience Therapeutics

Resilience Therapeutics Overview

Founded 2014
Status Private
Employees 8
Latest Deal Type Early Stage VC
Latest Deal Amount $500K
Latest Deal Amount
Investors 2

Resilience Therapeutics General Information


Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company's drug discovery engine is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Boston, MA
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 03-Mar-2016 $500K 00.000 Completed Startup
1. Angel (individual) 30-Jul-2015 00.000 00.000 00.00 Completed Startup

Resilience Therapeutics Cap Table

To view Resilience Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00

Resilience Therapeutics Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Azevan Pharmaceuticals Venture Capital-Backed Bethlehem, PA 0000 0000000000 0 0000
00000 0000000000 Formerly VC-backed Miramar, FL 00 00000 000000&0 00000
00000 000000000000 Corporation New York, NY 00 000000000000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
000 000000 00000 Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00

Resilience Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Brad Geddes Ph.D Co-Founder & Chief Operating Officer
Gregg Beloff JD Chief Financial Officer

4 Former Executives

Resilience Therapeutics Board Members (3)

To view Resilience Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Jason Fuller Ph.D Self Board Member 000 0000
William Cowan JD Self Board Member 000 0000

1 Former Board Member

Resilience Therapeutics Investors (2)

To view Resilience Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vodia Capital Asset Manager Minority 000 0000 000000 0
Jason Fuller Angel (individual) Minority 000 0000 000000 0

Ready to get started?

Request a free trial